Clinical and prognostic significance of CD4 expression in patients with de novo acute myeloid leukemia receiving intensive chemotherapy.
Although the lymphoid marker CD4 is aberrantly expressed in acute myeloid leukemia (AML), its clinical and prognostic significance remains poorly characterized. We retrospectively analyzed 217 patients with de novo AML receiving intensive chemotherapy. The clinical characteristics and survival outcomes were analyzed ac...